Bay BioSciences

Bay BioSciences is a private, revenue-generating services company that functions as a specialized provider of human biospecimens and biobanking solutions. Its core business model revolves around procuring and distributing hard-to-find, treatment-naïve human tissue samples, tumor specimens, and biofluids (e.g., serum, PBMCs) to accelerate biomedical research in oncology and immunology. Leveraging an IRB-approved global network of procurement sites, the company emphasizes rapid turnaround, ethical sourcing, and comprehensive patient data to support precision medicine and drug development. It positions itself as a critical enabler for research organizations needing reliable access to high-quality biological materials.

Integrated global biobanking and logistics network for ethical procurement, storage, and distribution of human biospecimens (tissues, biofluids) with comprehensive associated clinical data.

Competes with large, global biobanking CROs (e.g., Charles River Laboratories, LabCorp's Covance) and numerous niche specialty biospecimen providers. Differentiation is based on speed, focus on rare diseases, a dynamic global network, and the provision of comprehensive associated patient data.